Investing in biotech amid a recent pullback in the sector

This post was originally published on this site

Share

Jared Hotlz, Oppenheimer healthcare equity strategist, joins ‘Power Lunch’ to examine the biotech sector and where investors can find returns amid the sector’s recent pullback.

03:06

4 minutes ago